腾讯入股乐普医疗旗下创新药研发商民为生物

Group 1 - The core point of the article is the recent business change of Shanghai Minwei Biotechnology Co., Ltd., which has added Guangxi Tencent Venture Capital Co., Ltd. as a shareholder and increased its registered capital to approximately 16.16 million yuan [1] - Shanghai Minwei Biotechnology Co., Ltd. was established in 2021 and is focused on the development of innovative "multi-core macromolecular biopharmaceuticals" and platform development [1] - The major shareholder of Shanghai Minwei Biotechnology is Lepu Medical (300003), indicating a strategic partnership in the biopharmaceutical sector [1]